Anti-inflammatory effects of resveratrol in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials

This publication has 45 references indexed in Scilit:

• Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery Disease
  Cardiovascular Drugs and Therapy, 2012
• Resveratrol and health – A comprehensive review of human clinical trials
  Molecular Nutrition & Food Research, 2011
• Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular disease
  Annals of the New York Academy of Sciences, 2011
• Bioavailability of resveratrol
  Annals of the New York Academy of Sciences, 2011
• C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
  The Lancet, 2010
• Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography
  Journal of Chromatography B, 2007
• Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging
  International Journal of Obesity, 2003
• Quantifying heterogeneity in a meta‐analysis
  Statistics in Medicine, 2002
• Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
  Kidney International, 1999
• Wine, alcohol, platelets, and the French paradox for coronary heart disease
  The Lancet, 1992